Literature DB >> 33271342

A hierarchical clustering and data fusion approach for disease subtype discovery.

Bastian Pfeifer1, Michael G Schimek2.   

Abstract

Recent advances in multi-omics clustering methods enable a more fine-tuned separation of cancer patients into clinical relevant clusters. These advancements have the potential to provide a deeper understanding of cancer progression and may facilitate the treatment of cancer patients. Here, we present a simple hierarchical clustering and data fusion approach, named HC-fused, for the detection of disease subtypes. Unlike other methods, the proposed approach naturally reports on the individual contribution of each single-omic to the data fusion process. We perform multi-view simulations with disjoint and disjunct cluster elements across the views to highlight fundamentally different data integration behavior of various state-of-the-art methods. HC-fused combines the strengths of some recently published methods and shows superior performance on real world cancer data from the TCGA (The Cancer Genome Atlas) database. An R implementation of our method is available on GitHub (pievos101/HC-fused).
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disease subtyping; Integrative clustering; Multi-omics; Multi-view clustering

Year:  2020        PMID: 33271342     DOI: 10.1016/j.jbi.2020.103636

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  2 in total

1.  Multi-omics disease module detection with an explainable Greedy Decision Forest.

Authors:  Bastian Pfeifer; Hubert Baniecki; Anna Saranti; Przemyslaw Biecek; Andreas Holzinger
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

2.  Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.

Authors:  Lucas A Gillenwater; Shahab Helmi; Evan Stene; Katherine A Pratte; Yonghua Zhuang; Ronald P Schuyler; Leslie Lange; Peter J Castaldi; Craig P Hersh; Farnoush Banaei-Kashani; Russell P Bowler; Katerina J Kechris
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.